SCHEMBL4377558

SCHEMBL4377558

CC1CCCC(CN(C)C)C1(O)Cc1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.38
OPRD1 P41143 5/20 0.38
OPRK1 P41145 4/20 0.38
TAAR1 Q96RJ0 1/20 0.37
SLC6A2 P23975 6/20 0.37
SLC6A4 P31645 6/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
SLC22A1 O15245 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371073 0.86 SLC6A2 (0.38) OPRM1OPRD1OPRK1SLC6A2SLC6A4
SCHEMBL4374674 0.84 ALDH1A1 (0.38) OPRM1OPRD1OPRK1TAAR1SLC6A2
SCHEMBL4373652 0.81 GAA (0.38) OPRM1OPRD1OPRK1TAAR1SLC6A2
SCHEMBL4370558 0.80 SLC6A4 (0.36) OPRM1OPRD1OPRK1SLC6A2SLC6A4
SCHEMBL4369264 0.78 SMN1; SMN2 (0.42) OPRM1OPRD1OPRK1TAAR1SLC6A2
SCHEMBL4370590 0.77 SLC6A4 (0.36) OPRM1OPRD1OPRK1TAAR1SLC6A2
SCHEMBL4373148 0.74 OPRM1 (0.43) OPRM1OPRD1OPRK1SLC6A2SLC6A4
SCHEMBL4369362 0.74 TRPA1 (0.39) OPRM1OPRD1OPRK1TAAR1SLC6A2
SCHEMBL4374881 0.74 SLC6A4 (0.41) OPRM1OPRD1OPRK1SLC6A2SLC6A4
SCHEMBL4371916 0.74 EPHX2 (0.39) OPRK1SLC6A2SLC6A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322592-B2 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2009-06-17 EP claimed
US-7022739-B2 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2006-04-04 US claimed
EP-1322592-B1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP claimed
CN-1466567-A Substituted 1-aminobutan-3-01 derivatives 2004-01-07 CN claimed
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2003-11-20 US claimed
EP-1322592-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP claimed
WO-2002028817-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2002-04-11 WO claimed
EP-1322592-B2 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2009-06-17 EP disclosed
CN-100391933-C Substituted 1-aminobutan-3-01 derivatives GRLENTHAL GMBH (DE) 2008-06-04 CN disclosed
US-7022739-B2 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2006-04-04 US disclosed
EP-1322592-B1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES GRUENENTHAL GMBH (DE) 2004-07-28 EP disclosed
CN-1466567-A Substituted 1-aminobutan-3-01 derivatives 2004-01-07 CN disclosed
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds GRUENENTHAL GMBH (DE) 2003-11-20 US disclosed
EP-1322592-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2003-07-02 EP disclosed
WO-2002028817-A1 SUBSTITUTED 1-AMINOBUTAN-3-OL DERIVATIVES Grünenthal GmbH (DE) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216393-A1 Substituted 1-aminobutan-3-ol compounds CYP3A43, UGT1A3, UGT2B7 OPRM1 118/4885OPRD1 103/4885OPRK1 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.